| 英文别名： |
Enrofloxacin;1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;Enrofloxacin Hcl;1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-quinolinecarboxylic acid;1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-quinoline-3-carboxylic acid;1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethylpiperazino)-quinoline-3-carboxylic acid;1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic;Baytri;bayvp2674;BAY-Vp2674;Enrofoxacin;Enrolfoxacin;PD160788;ROFLOXACIN BASE;WAKO059-07471;1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid;Baytril;Enrofloxacine;CFPQ;Enrofloxacino;Enrofloxacinum;endrofloxicin;BAY VP 2674;Enrofloxacine [French];Enrofloxacinum [Latin];Enroxil;Enrofloxacino [Spanish];1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;N-Ethylciprofloxacin;Baytril (TN);ERFX;Enrofloxacin [USAN:BAN:INN];3DX3XEK1BN;Enrofloxacin (USAN/INN);3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-;1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid (ACI);1-Cyclopropyl-6-fluoro-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;1-Cyclopropyl-7-(4-ethyl-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid;1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid;Alsir;BAY-Vp 2674;Bayrocin;Biofloxavet;Enflocyna Sol;Enrocin;Enrodac;Enrofan;Enroflon;Enrogil;Enrovet;Fortius;N-Ethyl ciprofloxacin;N′-Ethylciprofloxacin;PD 160788;BAY Vp 2674;Enrofloxacin for system suitability |
沪公网安备 
